Harmless virus could predict dangerous complications after heart transplant
NCT ID NCT05064462
Summary
This study looked at whether tracking levels of a common, harmless virus (TTV) in the blood could help predict infections or organ rejection in heart transplant patients. Researchers followed 60 patients for their first year after transplant, measuring the virus monthly. The goal was to see if this simple blood test could become a useful tool to help doctors better manage anti-rejection medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU de Rennes
Rennes, 35033, France
-
Hôpital européen Georges Pompidou
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.